| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Wogonin | Diabetes Type 2 | 2 | PM | 35158145 | 📋 | Research progress of active ingredients of Scutellaria baicalensis in the treatment of type 2 diabetes and its complications |
| Wogonin | Diabetes Type 2 | 1 | PM | 31333118 | 📋 | Wogonin Alleviates Hyperglycemia Through Increased Glucose Entry Into Cells Via AKT/GLUT4 Pathway |
| Wogonin | Hyperglycemia | 2 | PM | 34711151 | 📋 | Wogonin and alleviation of hyperglycemia via inhibition of DAG mediated PKC expression. A brief insight |
| Wogonin | Hyperglycemia | 1 | PM | 31333118 | 📋 | Wogonin Alleviates Hyperglycemia Through Increased Glucose Entry Into Cells Via AKT/GLUT4 Pathway |
| Wogonin | Metabolic Disorders | 2 | PM | 36235573 | 📋 | Wogonin, a Compound in Scutellaria baicalensis, Activates ATF4-FGF21 Signaling in Mouse Hepatocyte AML12 Cells |
| Wogonin | Metabolic Disorders | 1 | PM | 35770725 | 📋 | Wogonin Ameliorated Obesity-Induced Lipid Metabolism Disorders and Cardiac Injury via Suppressing Pyroptosis and Deactivating IL-17 Signaling Pathway |
